Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658312 | SCV000780084 | pathogenic | not provided | 2018-05-21 | criteria provided, single submitter | clinical testing | A pathogenic variant has been identified in the TSC2 gene. The c.1946+1 G>T splice site variant in the TSC2 gene destroys the canonical splice donor site in intron 18. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.1946+1 G>T variant is not observed in large population cohorts (Lek et al., 2016). Additionally, a different nucleotide change at the same canonical donor site has been identified in a patient with a clinical diagnosis of TSC in the published literature (TSC2 LOVD; Sancak et al., 2005). Although this pathogenic variant has not been previously reported to our knowledge, its presence is consistent with the diagnosis of TSC in this individual. |